Browsing Category
Biotech News
279 posts
Biotech News
Biomatter lands $18M from Astanor and UVC Partners to build a Vilnius enzyme lab
Enzymes power processes across pharmaceuticals, food production, diagnostics and industrial manufacturing. However, developing a custom enzyme for a…
November 12, 2026
Paris-based Orakl Oncology scoops $34M for AI cancer drug prediction
Orakl Oncology, a Paris-based TechBio company that combines AI with patient biology, has raised $34 million in a…
November 12, 2026
Why Lilly and Boehringer backed a German startup’s mRNA ‘on-off switch’ in a €31.5M seed
SRTD Biotech, a German startup, closed an oversubscribed €31.5 million seed round, co-led by Mérieux Equity Partners via…
November 9, 2026
Swiss biotech Nouscom secures $135M, pushing cancer prevention vaccine forward
Nouscom’s co-founder and original chief executive, Riccardo Cortese, died in 2017, the year after Marina Udier joined the…
October 19, 2026
How anti-FUK antibodies support cancer research: A look at biotech research tools
Glycosylation is a natural cellular process in which sugar molecules, called glycans, are attached to proteins, lipids, or…
October 16, 2026
Exclusive: Sheffield spinout Silvia Bio raises £3M from Northern Gritstone to cut the cost of making biologic drugs
Silvia Bio, a spinout from the University of Sheffield that has now raised £3 million, led by Northern…
October 15, 2026
DeepMind spinout Isomorphic Labs eyes $40B valuation less than five months after $2.1B round: Report
When Isomorphic Labs raised $2.1 billion in May, it did not say what the round valued the company…
October 9, 2026
London startup Cori Clinical raises $4M to cut the cost of clinical trial protocol amendments
Three in four clinical trial protocols need amending at least once, according to the Tufts Center for the…
October 7, 2026
Eli Lilly, PGGM and KfW Capital back Forbion’s €2.3B fund for 30 biotechs
Biotech is short of capital. That is the view of Forbion‘s own co-founder, whose firm has nonetheless raised…
October 7, 2026